Market Place
Sourcing Support
All News #Library
Biotech
Werewolf Therapeutics: Q4 & FY 2025 Results, Corporate Updates
27 Mar 2026 //
GLOBENEWSWIRE
Werewolf Therapeutics Announces Pipeline And Business Updates
18 Dec 2025 //
GLOBENEWSWIRE
Werewolf Therapeutics Expands PREDATOR Platform Data at SITC
07 Nov 2025 //
GLOBENEWSWIRE
Werewolf Therapeutics To Present Posters At SITC Meeting
03 Oct 2025 //
GLOBENEWSWIRE
Werewolf Therapeutics Reports Q1 2025 Results and Update
08 May 2025 //
GLOBENEWSWIRE
Werewolf Therapeutics Announces New IL-10 INDUKINE™ Candidate
31 Oct 2024 //
GLOBENEWSWIRE
Werewolf`s WTX-124 Mono/Combo Data In Solid Tumors At ASCO
01 Jun 2024 //
GLOBENEWSWIRE
Werewolf Wtx-124 Updated Data: Phase 1/1b Mono/Pembro Combo Solids
23 May 2024 //
GLOBENEWSWIRE
Werewolf to Host Event Highlighting IL-2 Landscape and Opportunity for WTX-124
11 Sep 2023 //
GLOBENEWSWIRE
Werewolf Announces Initiation of Patient Dosing in Phase 1 Study of WTX-330
24 Feb 2023 //
GLOBENEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.